EFFECTIVE HALF-LIFE OF I-131 IN THYROID CARCINOMA PATIENTS RECEIVING LOW-DOSE ABLATION THERAPY WITH RTSH

被引：0
|
作者：
Willowson, K. [1 ]
Bailey, D. [2 ]
Forwood, N. [2 ]
Bailey, E. [2 ]
Roach, P. [2 ]
机构：
[1] Univ Sydney, Sydney, NSW 2006, Australia
[2] Royal N Shore Hosp, Dept Nucl Med, Sydney, NSW, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2012年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：35 / 35
页数：1
相关论文
共 50 条
  • [1] COMPARISON OF THE TRACER DOSE AND THE THERAPEUTIC DOSE OF I-131 AS TO THYROID UPTAKE, EFFECTIVE HALF-LIFE, AND ROENTGEN DOSAGE
    SEED, L
    JAFFE, B
    RADIOLOGY, 1954, 63 (04) : 551 - 561
  • [2] THE HALF-LIFE OF I-131
    SELIGER, HH
    CAVALLO, L
    CULPEPPER, SV
    PHYSICAL REVIEW, 1953, 90 (03): : 443 - 443
  • [3] THE HALF-LIFE OF I-131
    SREB, JH
    PHYSICAL REVIEW, 1951, 81 (04): : 643 - 643
  • [4] Efficacy of Low-Dose I-131 Therapy for the Postoperative Ablation of Low-Risk Differentiated Thyroid Cancer Patients
    Caglar, M.
    Bozkurt, F.
    Kapulu, C.
    Ugur, O.
    Bayraktar, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S344 - S344
  • [5] BIOLOGIC HALF-LIFE OF I-131 IN THE THYROID OF HEALTHY MALES
    ROSENBERG, G
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1958, 18 (05): : 516 - 521
  • [6] Effective half-life of 131I in thyroid cancer patients
    North, DL
    Shearer, DR
    Hennessey, JV
    Donovan, GL
    HEALTH PHYSICS, 2001, 81 (03): : 325 - 329
  • [7] EFFECTIVE HALF-LIFE OF I-131 DURING TREATMENT OF AUTONOMOUS THYROID-DISEASE
    MULLER, B
    BARES, R
    BULL, U
    NUKLEARMEDIZIN, 1991, 30 (03) : 71 - 76
  • [8] Predictive factors for the outcomes of initial I-131 low-dose ablation therapy to Japanese patients with differentiated thyroid cancer
    Ito, Shinji
    Iwano, Shingo
    Kato, Katsuhiko
    Naganawa, Shinji
    ANNALS OF NUCLEAR MEDICINE, 2018, 32 (06) : 418 - 424
  • [9] Predictive factors for the outcomes of initial I-131 low-dose ablation therapy to Japanese patients with differentiated thyroid cancer
    Shinji Ito
    Shingo Iwano
    Katsuhiko Kato
    Shinji Naganawa
    Annals of Nuclear Medicine, 2018, 32 : 418 - 424
  • [10] 131I effective half-life (Teff) for patients with thyroid cancer
    Willegaignon, J.
    Malvestiti, Luiz F.
    Guimaraes, Maria I. C.
    Sapienza, Marcelo T.
    Endo, Irene S.
    Neto, Guilherme C.
    Marone, Marilia
    Sordi, Gian-Maria A. A.
    HEALTH PHYSICS, 2006, 91 (02): : 119 - 122
12345